Acuvax

Acuvax (ACU)

Stock Code

ACU

Stock Exchange

ax

ACU is an international biotechnology company developing a product portfolio of a broad range of oncology-related products. The company is currently involved in a pancreatic cancer drug (RP101), which is in phase II clinical studies, and Pentry's anti-cancer vaccine, which is being evaluated in prostate cancer patients. Pentry targets one of the most common defects in cancer cells - a mutated p53 gene. Acuvax Limited (ACU) was listed on the ASX in August 1971. Its headquarters are situated in Sydney. ACU was renamed to its current name in December 2008.

Acuvax Dividends

18 October, 2010 - 01:05

Study the dividend records for Acuvax. Dividends are payments made by a corporation to its shareholder members. It is the portion of corporate profits paid out to stockholders. If Avantogen Limited has declared a dividend, you may be eligible to receive ACU dividends if the investor the company's stock on the ex-dividend date. Investors must have purchase the shares before the ex dividend date to be entitled to the dividend declared by the company. If you buy the stocks on or after the ex dividend date, the previous owner of the shares will receive the dividend.

Syndicate content

Recommended Websites